|Net Assets||2.25 Bil|
- Last NAV update 4/22/2014 4:00 PM ET
|The investment seeks a positive total return. The fund is a diversified investment that invests substantially all of its investable assets in the GMO Benchmark-Free Allocation Fund, an investment company managed by Grantham, Mayo, Van Otterloo & Co. LLC. The asset classes include: U.S. and foreign equity, including emerging markets; U.S. and foreign fixed income, including emerging markets; and alternative asset classes, including real estate and commodities. Benchmark-Free Allocation Fund is structured as a fund of funds and gains its investment exposures primarily by investing in the GMO Implementation Fund. The fund is non-diversified.|
- Year to date performance as of 4/22/2014 12:00 AM ET
|Fund Family||Wells Fargo Advantage|
|Fund Manager||Ben Inker|
|Minimum Initial Purchase||1,000.00|
|Minimum IRA Investment||250.00|
- * Annualized returns
- Performance as of 4/22/2014 12:00 AM ET
|Net Assets||2.25 Bil||770.85 Mil|
|Avg Market Cap||52.62 Bil||36.80 Bil|
|NAME||% NET ASSETS|
|GMO Benchmark-Free Allocation MF||99.82%|
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.